US-Anleger zeigen sich besorgt Virus beschert Wall Street satte Verluste

Many US investors are concerned about the spread of the new corona virus. Wall Street recorded its highest daily loss since October at the start of the week. Airlines and tourism groups in particular suffer.

Wall Street posted the highest daily loss since early October. Despite drastic measures in China with the quarantine of over 45 million people, the new corona virus spread further, fueling the fear of an uncontrollable pandemic. The number of deaths, but also that of the infected, had skyrocketed. At least 110 suspected cases have also been reported in the United States. The fear of a pandemic was accompanied by concerns about a global economic downturn.

Nasdaq composite
Nasdaq Composite 9,202.96
"Aside from human tragedy and cold market logic, the corona virus could have what it takes to take some heat out of the market, which has just climbed very quickly in the past few months," said Jasper Lawler of London Capital Group. Other market observers also spoke of a welcome occasion to take profits. The Dow Jones index lost 1.6 percent to 28,536 points, S&P 500 and Nasdaq composite lost 1.6 and 1.9 percent, respectively.

Manufacturer of protective masks benefits
American Airlines
American Airlines 26.42
Shares that were particularly affected by the effects of the virus were sold once again. The titles of the airlines American Airlines, United Airlines and Delta Air Lines lost up to almost 5.6 percent. In the tourism sector, it hit Royal Caribbean Cruises at a discount of 7.6 percent. Hotel and casino operator Las Vegas Sands lost 6.8 percent.

Exxon Mobil closed with the sharp drop in oil prices at minus 2.4 percent, the lowest level since October 2010. There were also stocks that were driven by the virus headlines: Alpha Pro Tech soared by over 28 percent. The manufacturer of protective masks is likely to benefit from the epidemic, according to market speculation. Meanwhile, the vaccine manufacturers and diagnostics specialists' papers were bullish: Co-Diagnostics by 82.4 percent, NanoViricides by 87 percent, Allied Healthcare Products by 50 percent and Inovio Pharmaceuticals by 25.5 percent. AbbVie climbed 0.6 percent. The pharmaceutical company announced sales at Allergan, which the group is currently taking over. Allergans were 0.4 percent firme